Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-crystalline Megestrol Acetate in High-risk HNSCC
NCT06772428Phase 3Not yet recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jan 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in anorexia-cachexia syndrome (ACS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
anorexia-cachexia syndrome (ACS)
Beyond the preview
Go deeper on NCT06772428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06772428.